Found: 12
Select item for more details and to access through your institution.
Pancreatic glucagonoma presenting as a pulmonary mass.
- Published in:
- Clinical & Translational Oncology, 2009, v. 11, n. 1, p. 60, doi. 10.1007/s12094-009-0312-3
- By:
- Publication type:
- Article
Idiopathic and recurrent thromboembolic phenomena in cancer patients.
- Published in:
- Clinical & Translational Oncology, 2008, v. 10, n. 10, p. 665, doi. 10.1007/s12094-008-0268-8
- By:
- Publication type:
- Article
Molecular biology of pancreatic cancer.
- Published in:
- Clinical & Translational Oncology, 2008, v. 10, n. 9, p. 530, doi. 10.1007/s12094-008-0247-6
- By:
- Publication type:
- Article
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA.
- Published in:
- Genome Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.1186/s13073-023-01171-w
- By:
- Publication type:
- Article
Effect of a Novel Food Rich in Miraculin on the Oral Microbiome of Malnourished Oncologic Patients with Dysgeusia.
- Published in:
- Cancers, 2024, v. 16, n. 19, p. 3414, doi. 10.3390/cancers16193414
- By:
- Publication type:
- Article
Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy.
- Published in:
- Molecular Diagnosis & Therapy, 2015, v. 19, n. 6, p. 397, doi. 10.1007/s40291-015-0165-0
- By:
- Publication type:
- Article
VARIABLES ASOCIADAS AL DETERIORO COGNITIVO EN PACIENTES DE CÁNCER DE COLON.
- Published in:
- Psicooncologia, 2011, v. 8, n. 2/3, p. 301, doi. 10.5209/rev_PSIC.2011.v8.n2-3.37883
- By:
- Publication type:
- Article
CHEMOBRAIN: REVISIÓN DE ESTUDIOS QUE EVALÚAN EL DETERIORO COGNITIVO DE SUPERVIVIENTES DE CÁNCER TRATADOS CON QUIMIOTERAPIA.
- Published in:
- Psicooncologia, 2011, v. 8, n. 2/3, p. 265, doi. 10.5209/rev_PSIC.2011.v8.n2-3.37881
- By:
- Publication type:
- Article
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-38364-y
- By:
- Publication type:
- Article
Efficacy and Safety of Habitual Consumption of a Food Supplement Containing Miraculin in Malnourished Cancer Patients: The CLINMIR Pilot Study.
- Published in:
- Nutrients, 2024, v. 16, n. 12, p. 1905, doi. 10.3390/nu16121905
- By:
- Publication type:
- Article
Effect of Regular Consumption of a Miraculin-Based Food Supplement on Taste Perception and Nutritional Status in Malnourished Cancer Patients: A Triple-Blind, Randomized, Placebo-Controlled Clinical Trial-CLINMIR Pilot Protocol.
- Published in:
- Nutrients, 2023, v. 15, n. 21, p. 4639, doi. 10.3390/nu15214639
- By:
- Publication type:
- Article
Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.
- Published in:
- PLoS ONE, 2017, v. 12, n. 9, p. 1, doi. 10.1371/journal.pone.0183452
- By:
- Publication type:
- Article